Robinhood benefited from a surge in investor activity as customers piled into stocks and cryptocurrencies. Eli Lilly and ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Sleep-apnoea-tackling Resmed is dreaming big but the question is: what can upset the Aussie biotech's growth story?

Two healthcare stocks that may or may not be boring, but that regardless look like strong growth stocks to invest in this ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Some of the market’s biggest winners start off as the smallest players. While trillion-dollar tech giants like the ...

Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...

All of a sudden, Amgen stock is up 15% since late December to around $299. Its rise helped push up the healthcare sector up ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Lilly upgraded its 2025 guidance to between $58 billion to $61 billion, slightly higher than Wall Street expectations by $1 ...